To continue reading this article, sign up for FREE to
Membership is FREE
and provides you with
instant access
to email newsletters, digital publications, our full content catalogue & more...
Oxford Gene Technology Grants Microarray Licence to Febit
Oxford Gene Technology (OGT) has announced that it has granted a microarray licence to febit biotech gmbh.
Dr Mike Evans, Chief Executive of OGT, said, “We are happy to support febit biotech’s technology by granting this licence and thus further the use of microarray technology”.
Peer Stähler, CSO of febit biotech gmbh said, “The agreement with OGT strengthens our IP and places us in a position to successfully market Geniom® worldwide”.
The acquired licence refers to the “Southern array patents”, fundamental patents covering the manufacture and use of DNA microarrays, and will remain valid for the patents’ lifetime.
Add Technology Networks as a preferred Google source to see more of our trusted coverage.
